MIDTERM CERTIFICATION TEST 2026 STUDY
GUIDE SCRIPT
◉ Question 28: A Nurse Practitioner is to use a single-dose 1 mL vial
to administer 0.5 mL of epoetin alfa to a 39-year-old woman who is
being treated for chemotherapy-induced anemia. Which of the
following will the nurse do with the unused portion of the drug?
Answer:
◉ Answer: Discard the unused portion of the drug. Answer:
◉ Question 29: A 36-year-old woman with a history of
dysmenorrhea has begun treatment with progesterone, which she
will be received by the intramuscular route. The nurse participating
in the woman's care should prioritize which of the following
potential nursing diagnoses? Answer:
◉ Answer: Risk for Injury related to loss of vision or thrombotic
events Answer:
◉ Question 30: A 33-year-old man has developed acute gouty
arthritis. He has been prescribed colchicine. When developing a care
,plan for this patient, which factor will be most important for the
nurse to consider? Answer:
◉ Answer: Dietary habits Answer:
◉ Question 31: A Nurse Practitioner is obtaining baseline physical
data from a 7-year-old patient who is to be started on
dextroamphetamine for ADHD. After obtaining vital signs, height,
and weight, the nurse will prepare the patient for an Answer:
◉ Answer: electrocardiogram (ECG). Answer:
◉ Question 32: Mr. Lepp is a 63-year-old man diagnosed with colon
cancer several weeks ago and is scheduled to begin chemotherapy.
He reports to the nurse that he read about the need for
erythropoietin in an online forum for cancer patients and wants to
explore the use of epoetin alfa with his oncologist. Which of the
following facts should underlie the nurse's response to Mr. Lepp?
Answer:
◉ Answer: The potential benefits of epoetin alfa must be weighed
carefully against the potential adverse effects in cancer patients
Answer:
, ◉ Question 33: A Nurse Practitioner has completed a medication
reconciliation of a patient admitted following a motor vehicle
accident. Rituximab is among the many drugs the patient has
received in the previous year. The nurse would be justified in
suspecting the patient may have received treatment for the following
diseases. Answer:
◉ Answer: Non-Hodgkin's lymphoma Answer:
◉ Question 34: An oncology nurse is aware of the risk for injury
related to the preparation, transportation, and administration of
chemotherapeutic agents. In order to reduce these risks, the nurse
should take the following actions? Answer:
◉ Answer: Prime the IV tubing with an approved IV solution rather
than the drug itself. Answer:
◉ Question 35: A patient is receiving long-term clindamycin therapy
for a life-threatening infection. The nurse will begin by monitoring
this drug therapy by obtaining Answer:
◉ Answer: a baseline CBC Answer: